NASDAQ: AVXL
Anavex Life Sciences Corp Stock Forecast, Predictions & Price Target

Analyst price target for AVXL

Based on 2 analysts offering 12 month price targets for Anavex Life Sciences Corp

Min Forecast
$42.00+367.71%
Avg Forecast
$44.00+389.98%
Max Forecast
$46.00+412.25%

Should I buy or sell AVXL stock?

Based on 2 analysts offering ratings for Anavex Life Sciences Corp.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although AVXL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates AVXL as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their AVXL stock forecasts and price targets.

AVXL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-07
lockedlocked$00.00+00.00%2025-10-02

1 of 1

Forecast return on equity

Is AVXL forecast to generate an efficient return?

Company
N/A
Industry
96.99%
Market
-62.31%

Forecast return on assets

Is AVXL forecast to generate an efficient return on assets?

Company
N/A
Industry
35.85%

AVXL earnings per share forecast

What is AVXL's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.49

AVXL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AVXL$8.98$44.00+389.98%Strong Buy
TYRA$14.50$32.00+120.69%Strong Buy
AKBA$2.93$7.50+155.97%Buy
DNA$13.25$9.00-32.08%Strong Sell
GERN$1.20$1.25+4.17%Sell

Anavex Life Sciences Stock Forecast FAQ

Is Anavex Life Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AVXL) stock is to Strong Buy AVXL stock.

Out of 2 analysts, 1 (50%) are recommending AVXL as a Strong Buy, 1 (50%) are recommending AVXL as a Buy, 0 (0%) are recommending AVXL as a Hold, 0 (0%) are recommending AVXL as a Sell, and 0 (0%) are recommending AVXL as a Strong Sell.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.

What is AVXL's earnings growth forecast for 2026-2026?

(NASDAQ: AVXL) Anavex Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 4.12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16%.

Anavex Life Sciences's earnings in 2025 is -$48,170,000.

In 2026, AVXL is forecast to generate -$42,087,979 in earnings, with the lowest earnings forecast at -$42,087,979 and the highest earnings forecast at -$42,087,979.

What is AVXL's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AVXL) forecast ROE is N/A, which is considered weak.

What is AVXL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AVXL price target, the average AVXL price target is $44.00, with the highest AVXL stock price forecast at $46.00 and the lowest AVXL stock price forecast at $42.00.

On average, Wall Street analysts predict that Anavex Life Sciences's share price could reach $44.00 by Oct 7, 2026. The average Anavex Life Sciences stock price prediction forecasts a potential upside of 389.98% from the current AVXL share price of $8.98.

What is AVXL's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: AVXL) Anavex Life Sciences's current Earnings Per Share (EPS) is -$0.57. In 2026, AVXL's EPS is forecast to hit -$0.49 (min: -$0.49, max: -$0.49).

What is AVXL's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AVXL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 35.85%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.